TECH vs TMHC · P/E 65, rev $1.22B vs P/E 11, rev $8.17B
Bio-Techne Corp (TECH) versus Taylor Morn Home (TMHC) — a side-by-side from cached financials, not a winner call.
Bio-Techne Corp (TECH) is a biotechnology company listed on US.
Taylor Morn Home (TMHC) is a residential construction company listed on NYSE.
Latest reported TECH revenue for 2025-06-30 was $1.22B. Net income was $73.4M. Revenue was up 5.2% from 2024-06-30 to 2025-06-30. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
Latest reported TMHC revenue for 2024-12-31 was $8.17B. Net income was $886.6M. Revenue was up 10.1% from 2023-12-31 to 2024-12-31. TMHC currently screens at market cap $6.59B and trailing P/E 10.7.
TECH currently screens at market cap $8.49B and trailing P/E 65.2. TMHC currently screens at market cap $6.59B and trailing P/E 10.7.
Not investment advice. Open the TECH and TMHC stock pages for the full models.
Not investment advice.